Low Molecular Weight Heparin (Bemiparin)

About Laboratorios Farmaceuticos Rovi

Laboratorios Farmaceuticos Rovi is a publicly traded Spanish pharmaceutical company with a dual business model combining proprietary drug development and contract manufacturing. The company has demonstrated significant growth, reporting €743.5 million in operating revenue for 2025, driven by its specialty pharmaceuticals and CDMO segments. Rovi is strategically investing in R&D, with expenses increasing 47% in 2025, and has established key international partnerships, including a major collaboration with Roche. Its operations span over 60 countries, supported by four manufacturing plants.

Therapeutic Areas